By diversifying the biological effector functions of antibodies, class switch DNA recombination (CSR) plays a critical role in the maturation of the immune response. It is initiated by AIDmediated dC deamination, yielding dUs, and dU glycosylation by Ung in antibody switch (S) region DNA. Here we showed that the translesion DNA synthesis polymerase Rev1 directly interacted with Ung and targeted in an AID-dependent and Ung-independent fashion the S regions undergoing CSR. Rev1 -/-Ung +/+ B cells reduced Ung recruitment to S regions, DNA-dU glycosylation and CSR. This together with an S region spectrum of mutations similar to that of Rev1 +/+ Ung -/-B cells suggested that Rev1 operated in the same pathway as Ung, as emphasized by further decreased CSR in Rev1 -/-Msh2 -/-B cells. Rescue of CSR in Rev1 -/-B cells by a catalytically inactive Rev1 mutant showed that the important role of Rev1 in CSR is mediated by Rev1 scaffold, not enzymatic function.
INTRODUCTION
Class switch DNA recombination (CSR) and somatic hypermutation (SHM) are critical for the maturation of the antibody response. CSR endows antibodies with new biological effector functions by replacing the C H region with a C H region that lies downstream in the immunoglobulin heavy chain (IgH) locus (Xu et al., 2012) . SHM provides the structural substrate for antigen-mediated selection of higher affinity antibody mutants by introducing mainly point-mutations with rare deletions or insertions into rearranged Ig V(D)J sequence (Casali et al., 2006) . Both CSR and SHM involve activation-induced cytidine deaminase (AID)-mediated generation of DNA lesions and subsequent DNA repair (Liu and Schatz, 2009; Xu et al., 2012) . AID deaminates deoxycytosine (dC) residues to yield deoxyuridine (dU):deoxyguanine (dG) mispairs. These trigger DNA repair processes that lead to introduction of mutations in V(D)J regions and generation of double-strand DNA breaks (DSBs) in switch (S) regions, in which point-mutations are also introduced (Odegard and mice, the Ig Vλ gene mutation spectrum was altered: dC→dG transversions were virtually absent in the non-transcribed (coding) strand and reduced in the transcribed strand (Jansen et al., 2006) . The sharing of many DNA repair factors between SHM and CSR and the multiple functions of Rev1 in DNA repair, through interactions with different DNA repair factors (Hicks et al., 2010; Sharma et al., 2011; Xie et al., 2010) , prompted us to hypothesize that Rev1 is involved in CSR by interacting with other elements of the CSR machinery and enhancing their function/activity.
We have addressed the role of Rev1 in CSR in vivo and in vitro using Rev1 -/-mice injected with 4-hydroxy-3-nitrophenyl acetyl (NP)-conjugated chicken gamma globulin (NP-CGG) and B cells deficient in Rev1 or other CSR factors, including AID and Ung. We adapted bimolecular fluorescence complementation (BiFC) assays to study the direct interaction of Rev1 with Ung and Ung mutants. We performed chromatin immunoprecipitation (ChIP) assays using B cells deficient in AID, Rev1 or Ung to determine the AID-dependence of Rev1 recruitment to S regions as well as the role of Rev1 in recruitment of Ung to S regions. We also enforced expression of Rev1 mutants in Rev1 -/-B cells to rescue CSR in the absence of Rev1 catalytic activity. Finally, we generated double-knockout Rev1 -/-Msh2 -/-mice to ascertain whether Rev1 deficiency would virtually abrogate CSR when paired with Msh2 deficiency, as Ung deficiency does. Our experiments outline an important noncatalytic (scaffold) role of Rev1 in CSR; Rev1 recruits and/or stabilizes Ung to/on S regions and enhances Ung glycosylation activity.
RESULTS
If Rev1 is important in CSR, it should be expressed in germinal centers, where B cells undergo CSR at a high rate. Indeed, like AID, Rev1 protein was expressed in human tonsil germinal centers ( Figure S1A ). Accordingly, Rev1 expression was upregulated together with upregulation of critical CSR factors, including AID, Ung, HoxC4 and 14-3-3γ (real-time quantitative qRT-PCR) in mouse spleen and lymph nodes, which contain a large proportion of hypermutating and switching B cells but not in non-lymphoid organs ( Figure S1B ). Stimulation of B cells with bacterial lipopolysaccharides (LPS), LPS or CD154 plus IL-4, or LPS plus IFN-γ, which induce CSR to different Ig isotypes, upregulated Rev1 expression ( Figure S1C) ; this was associated with upregulation of AID, Ung, HoxC4 and 14-3-3γ and CSR (not shown). Thus, Rev1 is induced by CSR-inducing stimuli and is upregulated in B cells undergoing CSR.
Rev1 deficiency impairs the class-switched antibody response to NP-CGG
We used Rev1 -/-mice (Jansen et al., 2006) to address the role of Rev1 in CSR in vivo. Rev1 plays an important role in CSR, then its deficiency should lead to a significant impairment of Ig class-switching in a specific antibody response. In non-intentionally immunized Rev1 -/-mice, serum IgM titers were normal (not shown), but serum IgG1 and IgG3 concentrations were significantly lower than in their Rev1 +/+ littermates and comparable to those of age-and sex-matched Ung -/-mice ( Figure S2A ). We injected five pairs of 8-10 week-old littermate Rev1 -/-and Rev1 +/+ mice with NP 16 -CGG and measured serum total and NP-binding IgM and IgG1 titers 7 days after boost injection. Rev1 -/-mice showed reduced levels of total IgG1, NP 30 -binding IgG1 as well as high affinity NP 3 -binding IgG1, but not total IgM, NP 30 -or NP 3 -binding IgM, as compared to Rev1 +/+ mice ( Figure 1A ).
The defective anti-NP IgG1 antibody response in Rev1 -/-mice did not result from alteration of plasma cell or NP-specific memory B cell differentiation, as the proportions of (plasma) B220 lo CD138 + cells and (memory) CD38 hi B cells among NP-binding IgG1 B cells in Rev1 -/-mice were comparable to those of their Rev1 +/+ littermates ( Figures 1B and 1C ). In addition, it was not due to obvious defects in lymphoid differentiation, as in Rev1 -/-mice, the size of the spleen and lymph nodes, and number and size of Peyer's patches were normal (not shown), so were the numbers of B and (CD4 + and CD8 + ) T cells ( Figures 1D and 1E) . In Rev1 -/-mice, B cell proliferation and viability were also normal ( Figures 1F and 1G ). Further, after stimulation with LPS or LPS plus IL-4, Rev1 -/-B lymphocytes showed cell cycle parameters and cell division rates comparable to Rev1 +/+ cells ( Figures S3A and S3B ). Rev1 -/-mice, however, showed reduced germinal center IgG1 + PNA hi B220 + B cells (by 58% in the spleen) and IgA + PNA hi B220 + B cells (by 46% in Peyer's patches) (Figures 1H and 1I) . Thus, in spite of normal B cell proliferation and normal plasma cell and memory B cell differentiation, Rev1 deficiency impairs a specific class-switched antibody response, likely because of an intrinsic impairment in the CSR machinery.
Rev1 deficiency impairs CSR
To further determine the impact of Rev1 deficiency on CSR, we stimulated Rev1 -/-and Rev1 +/+ (spleen) B cells with LPS (to induce switching to IgG2b and IgG3), CD154 (IgG2b), LPS or CD154 plus IL-4 (IgG1 and IgE), LPS or CD154 and IFN-γ (IgG2a) and LPS or CD154 plus TGF-β1, IL-5, IL-4 and anti-δ mAb/dex (IgA). After 4 days, switched surface Igγ1 + , Igγ2a + , Igγ3 + and Igα + B cells were fewer (by as much as 61%, 75%, 91% and 76%, respectively) among Rev1 -/-than Rev1 +/+ B cells (Figures S3C and S3D ). Accordingly, secreted IgG1, IgG2a, IgG2b, IgG3, IgA and IgE, but not IgM were reduced in Rev1 -/-B cell cultures (Figure 2A ), despite Rev1 -/-B cell normal cell cycle and proliferation (Figures S3A, S3B, 2B and 2C) , and comparable numbers of CD138 + B220 lo plasma cells emerging from Rev1 -/-and Rev1 +/+ B cells ( Figure 2D ). Although profound, the CSR (to IgG1 and IgG3) impairment in Rev1 -/-B cells did not match that of Ung -/-B cells, as assessed by switched surface Igγ1 and Igγ3 expression ( Figure S2B ). It, however, resulted in secreted IgG1 and IgG3 levels virtually as low as those of Ung -/-B cells in vivo and in vitro (IgG3) ( Figure S2A and S2C). The reduced CSR in Rev1 -/-B cells reflected decreased (by as much as 83%) circle I H -Cμ transcripts (byproducts of CSR) and postrecombination Iμ-C H transcripts (resulting from CSR, reduced by as much as 86%) in these B lymphocytes, in spite of the normal levels of germline I H -C H (Iγ1-Cγ1, Iγ2a-Cγ2a, Iγ2b-Cγ2b, Iγ3-Cγ3, Iα-Cα and Iε-Cε) transcripts, which precedes DNA recombination, and normal expression of Aicda and Ung transcripts as well as AID and Ung proteins ( Figures 2E, 2F and 3) . Thus, Rev1 deficiency impairs CSR to all class-switched Ig isotypes without affecting germline I H -C H transcription or AID and Ung expression.
Rev1 -/-B cells show altered mutation spectrum in S region DNA
Mutations arise in S region DNA in B cells undergoing CSR (Maul and Gearhart, 2010) . To ascertain whether defective CSR in Rev1 -/-Ung +/+ B cells was associated with altered mutations in S regions, we sequenced the upstream region of Sμ DNA (nucleotides 4289-5168; GenBank accession no. J0040), which includes the sequence analyzed by others (Rada et al., 2002) , and compared the mutations with those in B cells from Rev1 +/+ Ung +/+ littermates and Rev1 +/+ Ung -/-mice. In B cells from Rev1 -/-Ung +/+ mice, the mutation frequency in Sμ was increased by almost 30% (p = 0.003) as compared to their Rev1 +/+ Ung +/+ littermates. An even greater increase in mutation frequency was detected in B cells from Rev1 +/+ Ung -/-mice, possibly due to a more severe defect in (error-free) DNA repair associated with Ung deficiency and/or simply reflecting inter-strain variations. Remarkably, while dC→dT or dG→dA transitions accounted for 53.7% of the mutations at dC/dG pairs in Rev1 +/+ Ung +/+ B cells, they accounted for 86% of the dC/dG mutations in Rev1 -/-Ung +/+ B cells (p < 0.0001) (Figure 4 ), a phenotype resembling that of Rev1 +/+ Ung -/-B cells (p = 0.98), suggesting that Rev1 and Ung function in the same CSR pathway.
Rev1 is recruited to S regions (in an AID-dependent fashion) to recruit/stabilize Ung
We further addressed the role of Rev1 in CSR by analyzing its recruitment to S regions. In B cells stimulated with LPS plus IL-4, which induces CSR to IgG1, but not IgG3, ChIP assays showed both Rev1 and Ung bound to Sγ1, but not to Sγ3 DNA; conversely, in B cells stimulated with LPS, which induces CSR to IgG3 but not IgG1, Rev1 and Ung were recruited to Sγ3, but not to Sγ1. Both Rev1 and Ung were recruited to Sμ. Like Ung (Ranjit et al., 2011) , Rev1 recruitment to S region DNA was abrogated in Aicda -/-B cells, indicating that Rev1 is recruited to S regions in response to AID-mediated lesions in DNA ( Figure 5A ). To determine whether Rev1 and Ung binding to S region DNA is interdependent, we performed ChIP assays utilizing anti-Rev1 and anti-Ung Abs in both Rev1 -/-and Ung -/-B cells. Ung binding to Sγ1 and Sγ3 DNA was impaired in Rev1 -/-B cells stimulated with LPS plus IL-4 and LPS, respectively, while Rev1 recruitment to Sγ1 and Sγ3 DNA was not affected by Ung deficiency (Ung -/-B cells), showing that the occupancy of S region DNA by Ung is dependent on Rev1, but occupancy of S region DNA by Rev1 is independent of Ung. Thus, Rev1 plays a role in recruiting and/or stabilizing Ung to/on S region DNA.
Rev1 directly interacts with Ung
If Rev1 is important for Ung recruitment/stabilization to/on S region DNA, then it must interact with Ung. To establish whether Rev1 can directly interact with Ung, rather than through a third party molecule, we adapted an ad hoc BiFC assay . We divided super-enhanced yellow fluorescent protein (sEYFP) coding sequence into two complementary moieties, one encoding the N-terminal 154 residues (sEYFP 1-154 ), the other encoding the C-terminal 84 residues (sEYFP 155-238 ); these were fused with Flag-tagged human Ung (Flag-Ungs-EYFP 1-154 ) and influenza hemagglutinin (HA)-tagged human Rev1 (HA-Rev1-sEYFP 155-238 ), respectively (Figures 5B). Once expressed, the two sEYFP moieties complemented each other and gave off strong yellow fluorescence, as a result of direct juxtaposition between Rev1 and Ung -had Rev1 and Ung interacted through a third "spacer" molecule, this would have prevented sEYFP 1-154 and sEYFP 155-238 from complementing each other and, therefore, giving off fluorescence. We then tested whether the interaction between Rev1 and Ung was through the Ung N-terminal region, which contains the PCNA/RPA interaction domain and RPA interaction domain, or the Ung Cterminal region, which contains the 231 WxxF 234 motif. BiFC assays involving human Rev1 and human Ung mutants containing 151 N-terminal residues (Flag-Ung 1-151 -sEYFP 1-154 ) or 229 C-terminal residues (Flag-Ung 85-313 -sEYFP 1-154 ) showed that Rev1 interacted with Ung through the Ung C-terminal region but not the N-terminal region ( Figures 5C and 5D ). Next, we determined whether the Ung 231 WxxF 234 motif was involved in the interaction with Rev1 -Ung mutants of the WxxF motif lacking the N-terminal region failed to restore CSR in Ung -/-B cells (Begum et al., 2009 ). We performed BiFC assays using human Ung molecules lacking N-terminal 1-84 amino acid residues and bearing the W231A, W231K, F234G or F234D mutation in 231 WxxF 234 motif. Each of these mutations reduced the ability of mouse Ung Δ1-86 to mediate CSR in Ung -/-B cells, without affecting Ung protein levels (Begum et al., 2009) . Accordingly, none of the four WxxF mutations (W231A, W231K, F234G or F234D) altered human Ung protein levels, but each impaired Ung interaction with Rev1 ( Figures 5D and 5E ). Thus, Rev1 directly interacts with Ung through the Ung 231 WxxF 234 motif to mediate CSR.
Rev1 deficiency impairs B cell Ung activity
To investigate whether in addition to recruiting/stabilizing Ung to/on S region DNA, Rev1 also enhances Ung function, we analyzed, using a double-strand DNA substrate containing an internal dU:dG mispair, the DNA-dU glycosylation activity of extracts from Rev1 +/+ Ung +/+ , Rev1 -/-Ung +/+ or Rev1 +/+ Ung -/-B cells that had been stimulated with LPS plus IL-4. While Rev1 +/+ Ung +/+ B cell extracts displayed abundant DNA-dU glycosylation activity, extracts from Rev1 -/-Ung +/+ B cells, in which Ung mRNA and protein levels were comparable to those in Rev1 +/+ Ung +/+ B cells ( Figures 2E and 2F ), showed a 75% reduction of DNA-dU glycosylation, as compared to Rev1 +/+ Ung +/+ B cells ( Figure 4F ). Rev1 +/+ Ung -/-B cell extracts showed only minimal residual DNA-dU glycosylation (5%, possibly due to the expression of DNA glycosylases other than Ung, such as Smug1). Thus, Rev1 enables or enhances Ung DNA-dU glycosylation function in B cells.
Double deficiency in Rev1 and Msh2 further impairs CSR
We reasoned that if Rev1 is important in recruitment/stabilization of Ung to/on S regions and critically enhances the activity of this enzyme, then the CSR defect brought about by Rev1 deficiency should compound that due to Msh2 deficiency, much in the same way that Ung deficiency abrogates CSR when combined with Msh2 deficiency, as in Ung -/-Msh2 -/-B cells, in which both Ung-dependent and Msh2-dependent CSR pathways are aborted (Rada et al., 2004) . We crossbred Rev1 -/-with Msh2 -/-mice to construct double knockout Rev1 -/-Msh2 -/-mice. In Rev1 -/-Msh2 -/-B cells, CSR to IgG1, IgG3, IgG2a or IgA was reduced by up to 96% as compared to Rev1 +/+ Msh2 +/+ and 50-60% as compared to single knockout Rev1 -/-Msh2 +/+ or Rev1 +/+ Msh2 -/-B cells, as shown by surface Ig expression, (Iμ-Cγ2a in B cells stimulated by LPS plus INF-γ), respectively, as compared to Rev1 +/+ Msh2 +/+ B cells ( Figure S4 ). They were also reduced as compared to Rev1 -/-Msh2 +/+ B cells (by 95% and 77%, respectively) and Rev1 +/+ Msh2 -/-B cells (by 91% and 65%, respectively). Thus, double Rev1/Msh2 deficiency further impairs CSR due to Msh2 deficiency, suggesting that Rev1 and Ung function in the same CSR pathway.
Enforced expression of catalytically inactive Rev1 in Rev1 -/-B cells rescues CSR
Our experiments strongly suggested that defective CSR in Rev1 -/-B cells was largely due to an impairment in recruitment/stabilization of Ung, leading us to hypothesize that Rev1 functions in CSR not as an enzyme, but rather as a structural (scaffold) element. To test our hypothesis, we enforced expression of five different human Rev1 cDNAs in Rev1 -/-B cells using constructs based on the S-003 retroviral expression vector (Sayegh et al., 2003) : (i) wild-type Rev1, (ii) Rev1 D570A/E571A (a mutant with two point-mutations in the central region, inactivating Rev1 catalytic activity), (iii) Rev1 1-827 (a C-terminal region truncation mutant, retaining the central and N-terminal regions), (iv) Rev1 333-1251 (a N-terminal region truncation mutant, retaining the central and C-terminal regions) or (v) Rev1 Δ334-826 (a truncation mutant lacking central region and, therefore, the DNA-binding domain) ( Figure  7A ). Enforced expression of Rev1 D570A/E571A , Rev1 1-827 or Rev1 333-1251 in Rev1 -/-B cells rescued in every case CSR to IgG1 at the level of wild-type Rev1, while enforced expression of Rev1 Δ334-826 did not, as assessed by IgG1 surface fluorescence analysis and quantitation of circle Iγ1-Cμ and post-recombination Iμ-Cγ1 transcripts ( Figures 7B and 7C) . Thus, the Rev1 scaffold function, mediated by the central region of the molecule, but not Rev1 enzymatic activity is required for CSR.
DISCUSSION
CSR entails (i) AID deamination of dCs in the IgH locus S regions to yield dUs and dU glycosylation by Ung leading to DSBs, and (ii) DSB repair by the combined intervention of DNA replication and repair factors. As a highly regulated biological process, CSR is mediated by a multi-component complex, whose assembly would be made possible by scaffold proteins (Xu et al., 2012) . As exemplified by our previous findings on 14-3-3 adaptors , such scaffold proteins can simultaneously interact with DNA and client proteins through different subunits or domains to greatly increase the specificity and efficiency of the CSR macromolecular machinery. Here we show that the Rev1 TLS polymerase plays an important scaffold role in CSR. Like AID and other critical CSR factors, such as Ung, HoxC4 and 14-3-3, it is induced by T-dependent (CD154:C40 engagement) and T-independent (TLR engagement) CSR-inducing stimuli and is expressed in a B cell differentiation stage-specific fashion (germinal center B cells). Rev1 is recruited to S region DNA in an AID-dependent fashion, directly interacts with Ung, recruits/ stabilizes Ung to/on S regions and enhances Ung-mediated DNA dU glycosylation. Thus, the important role of Rev1 in CSR is an expression of the (non-enzymatic) scaffold function of this TLS polymerase.
As a Y family TLS polymerase, Rev1 possesses a unique and distributive dC transferase catalytic activity (Nair et al., 2005; Prakash et al., 2005; Zhang et al., 2002) . Owing to its ability to interact with PCNA, ubiquitin and TLS polymerases η, ι, κ and ζ, Rev1 would recruit other TLS polymerases, thereby displaying multiple functions in different DNA repair processes (Hicks et al., 2010; Sharma et al., 2011; Xie et al., 2010) . Like TLS polymerases η, θ and ζ, Rev1 is involved in SHM by bypassing DNA lesions through its catalytic activity (Jansen et al., 2006; Masuda et al., 2009 ). Rev1 deficiency has been associated with a strand-biased defect in dC → dG transversions in hypermutating V(D)J genes, suggesting that during SHM, Rev1 preferentially inserts dCs across from dUs and/or abasic sites introduced by AID and Ung intervention (Jansen et al., 2006; Masuda et al., 2009 ). As we have shown here, despite normal expression of Ung, Rev1 -/-B cells greatly increased dC/dG transition mutations in S regions (point-mutations are introduced into the recombining S regions by the CSR machinery), a pattern similar to that of Ung -/-B cells, suggesting that Rev1 and Ung participate in the same CSR pathway. Thus, in the absence of Rev1 and, therefore, decreased Ung recruitment, dU residues in S regions would be replicated over, yielding dC/dG transitions, in the same way that they are in Ung -/-B cells.
The distinct scaffold and catalytic functions of Rev1 in CSR and V(D)J SHM, respectively, were also suggested by the observation that mice expressing a catalytically inactive Rev1 mutant displayed an altered mutation spectrum in IgH J H -iEμ region DNA, but B cells from these mice revealed normal CSR in vitro (Masuda et al., 2009 ). The two different Rev1 functions (scaffolding and catalytic) are consistent with the divergent mechanisms underpinning CSR and V(D)J SHM, which are mediated by separate AID domains (Shinkura et al., 2004) , and the different requirements for the induction of these two processes (Zan et al., 1999; Zan et al., 2000; Zan et al., 2003) . The Rev1 distinct functions are mediated by discrete regions (Guo et al., 2006; Mayca Pozo et al., 2011) : the N-terminal region contains the BRCT domain; the central region comprises the DNA-binding, Hsp90-binding and ubiquitin-binding motif, in addition to the DE motif (D570E571 in human Rev1), which is critical for catalytic activity; and the C-terminal region includes the PCNA interaction and TLS polymerase interaction domains. As we showed here, enforced expression of our N-terminal and C-terminal Rev1 truncation mutants in Rev1 -/-B cells (both truncation mutants included the full central region) restored CSR to levels comparable to that of Rev1 +/+ B cells, while the construct lacking the central (DNA-binding) region did not. Rescue of CSR was not dependent on the Rev1 DE motif within this central region, strongly arguing for a non-catalytic (scaffold) function for Rev1 in CSR. Further, our BiFC assays unequivocally showed that Rev1 directly interacts with Ung and does so through the conserved Ung WxxF motif. This motif was found to be important for CSR, and was hypothesized to mediate the interaction of Ung with a putative CSR co-factor (Begum et al., 2009 ), which we surmise here to be Rev1.
As we have shown here, Rev1 promotes Ung recruitment/stabilization to/on S region DNA and dU glycosylation in switching B cells; Rev1 localization to S regions required AID but not Ung, while Ung recruitment to S regions required Rev1. This novel Rev1 function would be made possible by the ability of Rev1 to recognize and bind to dU-containing DNA, as suggested by Rev1-mediated insertion of dC across from dU in DNA synthesis (Zhang et al., 2002) . Accordingly, our experiments proved that the central region of Rev1, which contains the DNA-binding domain, is critical for Rev1 function in CSR. In S regions, Rev1 would be recruited by DNA-bound AID, either directly, as suggested by our preliminary modeling (http://hexserver.loria.fr) (Pone and Casali, unpublished) , or indirectly, through, for instance, Hsp90. Indeed, Hsp90 can bind to and stabilize AID in CSR (Orthwein et al., 2010) and can specifically bind to Rev1 to yield stable and/or functional form(s) of Rev1 (Mayca Pozo et al., 2011) . In contrast to direct Ung-Rev1 interaction, Ung is unable to bind AID (Ranjit et al., 2011) , further suggesting that the putative stabilization of Ung on S region DNA by AID occurs, at least in part, through Rev1. Thus, Rev1 would be recruited by AID to S region DNA and it would directly interacts with both dU and Ung, thereby forming a complex within which Ung stably associates with and glycosylates dU for CSR to unfold.
Rev1 -/-B cells displayed normal cell cycle and proliferation, indicating that the CSR reduction reflected an inherent defect of the CSR machinery. The normal levels of germline I H -C H transcripts in Rev1 -/-B cells suggested that the defect in CSR was not due to alterations in chromatin accessibility at S regions. As Rev1 can associate with TLS DNA polymerase ζ, which consists of the catalytic Rev3 and the regulatory Rev7 subunits, to facilitate polymerase ζ function, we could not rule out the possibility that Rev1 also contributes to CSR by promoting the activity of Rev3, which has been suggested to catalyze fill-in reactions in the course of CSR-associated DSB repair by NHEJ (Schenten et al., 2009) . Nevertheless, our demonstration of: (i) further reduced CSR in double knockout Rev1 -/-Msh2 -/-B cells as compared to Rev1 -/-Msh2 +/+ B cells; (ii) predominance of dC/dG transitions at S region mutations in Rev1 -/-B cells, a pattern evocative of that of Ung -/-B cells, but different from that of human and mouse B cells deficient in DNA polymerase η (loss of dA/dT mutations) (Neuberger and Rada, 2007) , a TLS polymerase suggested to be recruited to Ig V(D)J region DNA by Rev1 during SHM (Hicks et al., 2010) ; and (iii) direct interaction of Rev1 with Ung, all support the notion that Rev1 mediates CSR mainly through its interaction with Ung. The residual CSR we detected in the Rev1 -/-Msh2 -/-B cells might reflect a residual recruitment/stabilization to/on S region DNA that was independent of Rev1. Indeed, as we have shown here, overall CSR in Rev1 -/-B cells was significantly impaired, but not virtually abrogated, as it was in Ung -/-B cells. Accordingly, DNA dU glycosylation activity of Rev1 -/-Ung +/+ B cell extracts was 25% of that in Rev1 ++ Ung +/+ and 5% of that in Rev1 +/+ Ung -/-B cells.
In CSR, both generation of DSBs and DSB repair entail multiple sequential enzymatic reactions on the recombining S region DNA. They would depend on the formation of a macromolecular complex, within which (non-enzymatic) scaffold elements, such as 14-3-3 and RPA, and enzymatic elements with scaffold functions, such as Rev1 and, possibly, AID stabilize themselves and other CSR factors on S regions -after dC deamination, AID likely persists on the IgH locus (Larijani et al., 2007) and acts a scaffold for other factors, including Rev1 (Xu et al., 2012) . Rev1 functions as a legitimate scaffold protein in CSR: it comprises different protein-interaction domains (for Ung and possibly AID) and coordinates the assembly of at least one relevant molecular component, Ung, in a macromolecular complex to increase the efficiency of a specific biological process: dU glycosylation. Accordingly, RPA also directly interacts with Ung, although deletion of the RPA-binding domains in the N terminus of Ung does not impair CSR (Begum et al., 2009 ). Ung molecules with both truncation of the N-terminus and mutations of the WxxF motif, which as we show here is critical for Rev1 interaction, or of D145 and N204 in the catalytic center, failed to mediate CSR (Begum et al., 2009) , suggesting that both RPA and Rev1 are required for full function of Ung in CSR. Thus, Rev1 together with Ung likely contributes to a DNA-protein macromolecular complex that also includes AID, 14-3-3 and RPA, and that is central to generation and resolution of S region DSBs.
EXPERIMENTAL PROCEDURES Mice
Rev1 -/-mice were generated by Dr. Niels de Wind (Leiden University, Netherlands) by deleting Rev1 exon 10, which encodes residues 557-609 including the conserved S(C/I)DE amino acid sequence essential for the catalytic activity (Jansen et al., 2006) . Both the catalytic domain and the C-terminal domain, which interacts with other TLS polymerases, are absent in these mice (Jansen et al., 2006) . Cells from Rev1 -/-mice express only shortened Rev1 transcripts and no Rev1 protein. Msh2 -/-mice (Nikitin et al., 2002) were obtained from Dr. Wen-Hwa Lee (University of California, Irvine). Ung -/-mice (Nilsen et al., 2000) were obtained from Dr. T. Lindahl (Cancer Research UK London Research Institute, South Mimms, UK). Rev1 -/-and Ung -/-mice were on mixed C57BL/6 -129 background, Msh2 -/-mice were on C57BL/6 background. Double knockout Rev1 -/-Msh2 -/-mice were generated by us by crossbreeding Rev1 -/-with Msh2 -/-mice.
The Institutional Animal Care and Use Committee (IACUC) of University of California, Irvine, approved all animal experiments.
NP 16 -CGG immunization and titration of total and NP-binding IgM and IgG1
Rev1 -/-and Rev1 +/+ mice (8-10 week-old) were immunized with 100 μg of NP 16 -CGG (16 molecules of 4-hydroxy-3-nitrophenyl acetyl coupled to one molecule of chicken γ-globulin (Biosearch Technologies) in Imject® alum (Pierce) for B cell and anti-NP antibody studies, as we described (Park et al., 2009; White et al., 2011 ).
B and T cells
B cells (B220 + ), CD4 + and CD8 + T cells, dead B cells, germinal center (PNA hi ) B cells, plasma cells (B220 lo CD138 + ) and NP-binding CD38 hi IgG1 + memory B cells were identified and analyzed in single cell suspensions using a FACSCalibur ™ flow cytometer (BD Biosciences) and specific mAbs. Germinal center (PNA hi B220 + ) B cells expressing IgG1 or IgA In vivo were determined by flow cytometry Park et al., 2009 ). Cell cycle of in vitro stimulated B cells was determined by analyzing the correlated expression of total DNA (indicated by 7-AAD intercalation) and incorporated BrdU levels using BD Pharmingen™ APC BrdU Flow Kit (BD Biosciences) following manufacturer's instructions. Proliferation of in vitro stimulated B cells was analyzed using the CellTrace™ CFSE Cell Proliferation Kit (Molecular Probes). Proliferation of B cells in mice immunized with NP 16 -CGG was measured by BrdU incorporation.
CSR
B cells were stimulated with LPS (5 μg/ml), LPS (5 μg/ml) or CD154-expressing membrane fragments of baculovirus-infected Sf21 insect cells ("CD154" here) plus appropriate cytokine(s) to induce CSR to different isotypes (Park et al., 2009; Pone et al., 2012a) , and then analyzed for surface Ig. Titers of IgG1, IgG2a, IgG2b, IgG3, IgA and IgE in culture supernatants of in vitro stimulated B cells were measured using specific ELISAs, as we described (Park et al., 2009; White et al., 2011) .
Quantitative real-time RT-PCR
Germline I H -C H , circle I H -Cμ, post-recombination Iμ-C H , HoxC4, Aicda, Rev1, Ung, and 14-3-3γ, Cd79b and Gapdh transcripts were analyzed by real-time quantitative RT-PCR (qRT-PCR) using specific primers as described previously (Park et al., 2009; White et al., 2011) or listed in the Supplemental Information.
DC-PCR
B cells were stimulated with LPS or LPS plus IL-4 for four days for isolation of genomic DNA and detection of recombinant Sμ-Sγ1 and Sμ-Sγ3 DNA by DC-PCR .
Somatic mutations in Sμ region DNA
Peyer's patch B cells switch and accumulate mutations in Sμ region at a high rate (Delbos et al., 2005) . Somatic mutations in Sμ regions were analyzed using genomic DNA prepared from Peyer's patch B cells from Rev1 +/+ Ung +/+ and Rev1 -/-Ung +/+ littermates and age matched Rev1 +/+ Ung -/-mice.
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as we described (Kim et al., 2004; Park et al., 2009; Schaffer et al., 2003; Xu et al., 2010) using rabbit Abs to Rev1 (H-300; Santa Cruz Biotechnology) and Ung (FL-313; Santa Cruz Biotechnology).
Bifluorescence complementation (BiFC)
The BiFC assay to analyze the direct interaction of Rev1 with Ung was adapted from our reported method . Briefly, 5 × 10 5 HeLa cells were transiently transfected using Lipofectamine™ (Invitrogen) with plasmids (0.5 μg each) expressing HA-(human) Rev1-YFP 155-238 and Flag-Ung-YFP 1-154 , Flag-Ung 1-151 -YFP 1-154 , or Flag-Ung 85-313 -YFP 1-154 proteins, or Ung WxxF mutants Flag-Ung W231A -YFP 1-154 , Flag-Ung F234G -YFP 1-154 , or Flag-Ung F234Q -YFP 1-154 , which were generated using the Rev1 interactionproficient Ung 85-313 truncation mutant (this human Ung molecule lacking residues 1-84 is equivalents to the mouse Ung lacking residues 1-86) as the starting construct, respectively. Cells were washed 24 hr after transfection, stained with 7-AAD and analyzed by flow cytometry.
DNA-dU glycosylation
Ung activity was measured using a 5′-[ 32 P]-labeled double-stranded oligonucleotide with an internal dU:dG mispair as previous reported (Di Noia and Neuberger, 2002; Zan and Casali, 2008) .
Rev1 and Rev1 mutant constructs and enforced expression
The human Rev1 cDNA was prepared from mRNA of human peripheral blood mononuclear cells. The catalytically inactive mutant Rev1 D570A/E571A , which contained two pointmutations at the D570E571 motif (D570A and E571A) -human Rev1 D570E571 is equivalent to mouse Rev1 D568E569 (Masuda et al., 2009; Ross et al., 2005) -was generated by site-directed mutagenesis. The constructs encoding the C-terminal deletion mutant Rev1 1-827 (retaining the central and N-terminal regions), the N-terminal deletion mutant Rev1 333-1251 (retaining the central and C-terminal regions) and the central region deletion mutant Rev1 Δ334-826 (retaining the N-terminal and C-terminal regions) were generated by PCR. Wild-type and mutant Rev1 cDNAs were cloned into the S-003 retroviral expression vector (Sayegh et al., 2003) (kindly from Dr. C. Murre, University of California, San Diego). For the generation of retrovirus, the constructs were transfected along with the pCL-Eco retrovirus-packaging vector (Imgenex) into the HEK293T cell line, pre-treated with 25 mM chloroquine, using the ProFection Mammalian Transfection system (Promega). The retroviral constructs were used to transduce Rev1 +/+ and Rev1 -/-B cells as reported (Sayegh et al., 2003) . Briefly, B cells were activated with LPS for 12 hr and then transduced with retrovirus. The transduced B cells were then stimulated with LPS plus IL-4 for 48 hr before analyzing CSR to IgG1 by semi-quantitative RT-PCR and qRT-PCR.
Immunohistochemistry
Paraffin-embedded human tonsil surgical specimens were serially sectioned with a cryostat at 6 μm onto glass slides and stained as we previously reported .
Statistical analyses
Differences in spectrum of mutations in Rev1 +/+ and Rev1 -/-mice were analyzed by Chisquared test. Differences in Ig titers, CSR and mRNA expression were analyzed with paired or unpaired t-tests.
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